Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Intellia Therapeutics (NTLA) over the last 11 years, with Q3 2025 value amounting to $12.5 million.

  • Intellia Therapeutics' Non-Current Deffered Revenue fell 4453.49% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year decrease of 4453.49%. This contributed to the annual value of $18.3 million for FY2024, which is 5301.26% down from last year.
  • Per Intellia Therapeutics' latest filing, its Non-Current Deffered Revenue stood at $12.5 million for Q3 2025, which was down 4453.49% from $12.5 million recorded in Q2 2025.
  • Intellia Therapeutics' Non-Current Deffered Revenue's 5-year high stood at $63.5 million during Q4 2021, with a 5-year trough of $12.5 million in Q2 2025.
  • Its 5-year average for Non-Current Deffered Revenue is $29.6 million, with a median of $25.7 million in 2022.
  • As far as peak fluctuations go, Intellia Therapeutics' Non-Current Deffered Revenue soared by 25198.92% in 2021, and later tumbled by 7198.52% in 2023.
  • Over the past 5 years, Intellia Therapeutics' Non-Current Deffered Revenue (Quarter) stood at $63.5 million in 2021, then tumbled by 68.6% to $19.9 million in 2022, then skyrocketed by 94.93% to $38.9 million in 2023, then tumbled by 53.01% to $18.3 million in 2024, then tumbled by 31.32% to $12.5 million in 2025.
  • Its Non-Current Deffered Revenue was $12.5 million in Q3 2025, compared to $12.5 million in Q2 2025 and $13.2 million in Q1 2025.